 |
Edition: September 2021 |
|
 |
|
Table of Contents
|
|
Letter from the Editor |
For this month’s e-Brief, I would like to bring to broader attention a topic that has had heated interest throughout the ACR membership and leadership and which has had spirited discussion on the ACR Engage platform. For those who are not familiar with Engage, it is an online forum hosted at Click Here by the ACR that allows discussion among members on a variety of issues. Discussion is divided into communities, for example, “Body Imaging” or “Medical Physics” or “YPS” to collect members with similar interests. We encourage you to take a look and participate if it catches your interest! On Engage, there have been several recent discussions regarding MARCA (Medicare Access to Radiology Care Act – not to be confused with the quality-metric law MACRA). MARCA is a bill currently sponsored in the House, but without a current sponsor in the Senate. The bill was historically supported by the ACR due to longstanding relationships with the technologists’ professional society, ASRT, as well as other stakeholders, but recent member sentiment raising concerns about MARCA culminated in an organized ACR town hall on August 17, 2021, to allow commentary and debate on the subject. The recorded town hall is available at: Click Here
One of the most-discussed issues within MARCA is the proposed ability of Registered Radiology Assistants (RRAs) to bill Medicare incidents to a radiologist at 85% of the fee schedule, under “direct” supervision rather than “personal” supervision. When Medicare requires “personal” supervision, as for a fluoroscopy study, that means “in the room” or “at the elbow” of the midlevel extender. Currently, RRAs operate with “personal” supervision – the radiologist can bill 100% of the Medicare fee because the radiologist is at the side of the RRA while the procedure is being performed. MARCA proposes “direct” supervision, which is confusingly named. “Direct” supervision means the radiologist is within the radiology suite or hospital, but not alongside the RRA. When direct supervision is being performed, radiologist bills at 85% of the Medicare fee schedule. This is what happens when a PA or NP acts as a midlevel – the supervising physician (whether a radiologist or an orthopedist) is providing direct supervision and billing occurs either as a physician or directly as PA/NP at 85%. MARCA proposes a similar pattern for RRAs, allowing direct supervision at 85% billing, but also requiring that billing be “incident to” a radiologist. That is, with the law’s current wording the RRA cannot bill at 85% independently. This would allow RRAs to provide services for radiologists similar to what PAs and NPs can currently provide. According to the ACR town hall, there are currently approximately 500,000 PAs and NPs in the US, and less than 1000 RRAs: the current asymmetry in billing has been implicated in the slower uptake of RRAs as extenders. The August 17th town hall provided speakers discussing the pro, con, and neutral positions on the subject. Matthew Johnson, an academic Interventional Radiologist at Indiana University, provided a more extended “pro” position for the town hall, and Kurt Schoppe, a private practice radiologist from Radiology Associates of North Texas, provided a more extended “con” position. Q and A was taken verbally and via Zoom chat. Points for the “pro” position included: protecting an extender position with restrictions on practice and the requirement to work under a radiologist (unlike PAs and NPs), supporting colleagues at ASRT who advocate for RRAs, and helping radiologists who currently use RRAs to be able to bill for them with direct supervision. Points for the “con” position included: avoiding an extender who is uniquely radiology-trained and could potentially displace radiologists, forestalling scope creep and desire for independent practice, and favoring physicians and their trainees’ being more directly involved in patient care rather than extenders.
The ACR leadership is actively examining this issue and would like feedback from membership before making a decision on supporting the bill at the Council’s convening at the 2022 ACR Annual Meeting. The ACR would like to do an all-member survey on the issue, but state chapter feedback is critically important. The officers of the FRS want to hear the opinions of the FRS membership on the subject. Please contact us! Feel free to email me at juancarlos98@gmail.com or to call/text at my cell (617) 653-5600. The ACR and FRS are member-driven organizations, and our goal is to serve the constituency. On this particular issue, we would like to be able to know the will of the FRS before the next Council meeting. Thank you!
|
Juan Batlle, MD Secretary, FRS JuanCarlos98@gmail.com |
|
Meet Your 2021 – 2022 FRS Executive Committee |
 |
President Rajendra Kedar, MD, FACR
|
 |
President-Elect Chintan Desai, MD, FACR
|
 |
Treasurer Laura Vallow, MD
|
 |
Secretary Juan C Batlle, MD
|
 |
 |
|
|
 |
|
|
FRS President’s Message |
Radiologist and Artificial Intelligence (AI): Current Status
ACR data science institute recently conducted a survey of ACR members to learn how radiologists are using AI in practice. Approximately 33% of respondents said they are using some form of AI in their practice. The most common areas in which AI was used were image interpretation, worklist management, departmental operations, image enhancement, and automated measurements. Screening mammography (9%), pulmonary embolus (6.4%), MR brain analytics (5.9%), and brain hemorrhage (5.7%) were the most commonly used algorithms in clinical practice. Those using AI in clinical practice were using algorithms they created themselves rather than commercially developed products. Most AI users were satisfied with their overall experience with AI and agreed it provided value for them and their patients. Most of the inconsistency reported was due to bias as a major cause. The preferred solution for this was validation of AI models across representative data sets and performance of models on their own patent’s data.
Interestingly for those not using AI in their practices, 80% did not see any benefits. Approximately one-third of respondents reported that they cannot justify the expense or AI decision was not in their hands. Some were against the use of AI because of a concern about the decrease in their productivity. Of those not using AI, approximately 72% have no current plans to purchase AI, whereas approximately 20% see themselves purchasing AI tools in the next 1 to 5 years.
It is predicted that there will be a 10-fold increase in demand for AI over the next decade. The clinical needs of radiologists will drive innovation around the AI tools and will evolve around efficiency in daily workflow, and have the potential to improve the quality of patient care.
Source: 2020 ACR data science institute artificial intelligence survey. Allen B, Agarwal S, Coombs L et al: Click Here |
Very Respectfully, Rajendra Kedar, MD, FACR President, Florida Radiological Society Professor of Radiology, University of South Florida-Morsani College of Medicine Director- Body Imaging Education and Fellowship Chief-Dept of Radiology, Tampa General Hospital |
|
 |
Past President Patricia Mergo, MD, FACR |
 |
Legal Counsel Michael M. Raskin, M.D., J.D., FACR |
 |
|
|
|
FRBMA President’s Message |
How much effort should your group devote to your Artificial Intelligence (AI) Strategy? From the mid-seventies until about 2000 there were rapid technology changes in radiology. This was driven by innovation in three new modalities: CT, MRI, and PET. The first CT in the United States was installed in 1973. By 1980 the United States was performing 3 million CT procedures and by 2019 CT utilization in the United States was 80 thousand procedures. MRI and PET had similar growth trajectories. MRI was commercially available around 1985 and has grown to about 40 million (2019). PET was commercially available around 1995 and has grown to about 2 million PETs annually. It’s really remarkable the amount of innovation that occurred in 15 years.
Private practice groups did not significantly participate on the technical side of all of this growth. Hospitals and academic institutions more quickly adopted these technologies, and in many markets still have a dominant position.
Although the growth in these technologies mostly occurred in the hospital rather than a private radiology practice, I don’t feel this worked out badly for our specialty. I think we could have done more to take advantage of such a transformative period, but hospitals and private radiology groups have symbiotic relationships. We have benefitted from their growth and have taken no risk.
Corporate radiology has now entered our landscape. What if in 1980 there was a national radiology group with the scale, infrastructure, and capital funding similar to the current national radiology corporations? If one of them was around in 1980 they could have modified their strategy from a professional-only strategy to a strategy that pursued these new technologies. That would have taken volume away from the hospital setting where we operate and would have negatively impacted our future business opportunities. It also would have given them a solid platform in which to create value through efficiency, lower cost, and easier patient access. Had that occurred things could be very different than they are now.
It has been about 25 years since a disruptive technology occurred in our specialty. I believe that AI may be the next disruptive technology in radiology.
I have no inside information about how radiology corporations view AI. However, my guess is that they are participating in development with leading AI creators. Developing relationships and possibly entering into collaboration agreements. I don’t know how this will play out but I think there could be an opportunity similar to what occurred in the 1980s and 1990s.
My article last month talked about private vs corporate practice. And essentially, I said that for corporate radiology to be successful they have to create a value equation within the healthcare delivery system. Could AI be a component of that value equation? If it is, should we at least be as ready as corporate radiology might be?
Most of the discussions I have participated in dealt with AI viability, or if viable its relative impact on radiologist workflow or productivity. Should we consider a discussion on whether or not AI could change the competitive landscape and if so, what steps must we take?
|
John Detelich, CPA, MBA, CEO President, FRBMA jdetelich@radassociates.com |
|
|
 |
|
Legislative Update |
September is here and the first set of committee meetings are set for the week of September 20th. The courts have closed jury trials for 30 days due to the spread of the Delta variant. It will be interesting to see how the legislature handles the public and if we are allowed in the Capitol.
It is too early to tell what issues will be on the agenda as not many bills are filed and are not in the system yet. I anticipate that the scope expansion bills will be back before the legislature during the upcoming session.
Election fundraising is underway; so, please let me know if you have an interest in getting involved with your local state candidates. Please contact me at alisondudley@dudleyandassociates.com
Thank you for your support, stay safe and healthy. |
Thanks, and stay well, Alison Dudley, FRS Lobbyist AlisonDudley@dudleyandassociates.com |
|
 |
|
|
|
 |
 |
|
|
Job Posting Opportunities |
Florida Radiological Society is pleased to introduce the opportunity for interested parties to advertise for potential jobs in our monthly FRS Ebrief bulletin.
Advertisement pricing is as follows:
Ebrief Job Posting pricing: 3 months ($100 monthly) 6 months ($90 monthly) 12 months ($80 monthly)
Please contact Lorraine Roger, our Society Administrator for further information on how to advertise in our monthly publication. Phone: (813) 806-1070 Fax: (813) 806-1071 Email: lroger@flrad.org
We feel that this will provide a valuable service to both our members and our Florida community of Radiology.
|
Thank you for your interest! Patricia Mergo, MD, FACR |
|
 |
|
|
Become a PAC Member Today |
Attention FRBMA Members! Please support the cause. We encourage you to be PAC members and supporters; you do not have to belong to the FRS. Donations can be made online through our PAC website www.FLRADPAC.org. Thank you for your donation: Drs. Mergo and Williams.
It is critical that we support both our Florida PAC and RADPAC in order to bolster our voice in Tallahassee and Washington, respectively. Please join FRS lobbyist Alison Dudley in her special appeal for all Florida radiologists to become Florida PAC members. If you would like to help FRS defend radiology against untoward legislation and introduce bills that have a positive impact on our practices, we need your financial support to re-elect our friends in the state House and Senate. The FRS can also show you simplified ways on how to sign up your radiology group. Contact Lorraine Roger at lroger@flrad.org or contact Alison Dudley at alisondudley@dudleyandassociates.com for more information. |
|
|
 |
|
|
 |
 |
|
Telephone (813) 806-1070 • Fax (813) 806-1071 5620 W. Sligh Avenue • Tampa, Florida 33634 |
The E-Brief is an exclusive member benefit of Florida Radiological Society, delivering monthly member, chapter and industry news. Please do not reply to this automatic e-mail. For comments or questions about the E-Brief, please contact lroger@flrad.org. |
|
|